Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Roland Meisel, MD, Lisa Kuypers, Bernd Gruhn, MD, Gabi Strauss, MD, Brigitte Strahm, MD, Karoline Ehlert, MD, Karin Beutel, MD, Wolfgang Holter, MD, Renate Bluetters-Sawatzki, MD, Tobias Feuchtinger, MD, Hans-Peter Gruettner, MD, Ralf Schubert, PhD, Sabine Diedrich, MD, Marion Riffelmann, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2007) 110 (11): 164.

https://doi.org/10.1182/blood.V110.11.164.164

Published: 2007

Journal Articles

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Hans-Juergen Laws, MD, Helmut Hanenberg, MD, Silja Roettgers, PhD, Gritta Janka-Schaub, MD, Arndt Borkhardt, MD, Ulrich Goebel, MD, Dagmar Dilloo, MD

Blood (2007) 110 (11): 1431.

https://doi.org/10.1182/blood.V110.11.1431.1431

Published: 2007

Journal Articles

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Helmut Hanenberg, MD, Gritta Janka, MD, Ulrich Goebel, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2006) 108 (11): 2282.

https://doi.org/10.1182/blood.V108.11.2282.2282

Published: 2006

Journal Articles

Similar Survival after Bone Marrow Versus Peripheral Blood Stem Cell Transplantation from Matched Unrelated Donors in Children with Hematologic Malignancies.

Roland Meisel, MD, Hans-Juergen Laws, MD, Stephan Balzer, MD, Benedikt Bernbeck, MD, Christof Kramm, MD, Stephan Schoenberger, MD, Kumar Sinha, MD, Anja Troeger, MD, Peter Wernet, MD, Ulrich Goebel, MD, Juergen Enczmann, PhD, Dagmar Dilloo, MD

Blood (2005) 106 (11): 2066.

https://doi.org/10.1182/blood.V106.11.2066.2066

Published: 2005

Journal Articles

Vaccination with the Heptavalent Pneumococcal Conjugate Vaccine Prevenar™ Provides Early Protective Antibody Responses in Children after Allogeneic Stem Cell Transplantation.

Roland Meisel, MD, Uta Dirksen, MD, Ralf Schubert, PhD, Bernd Gruhn, MD, Gabriele Strauss, MD, Ulrich Duffner, MD, Andreas Groll, MD, Karin Beutel, MD, Renate Bluetters-Sawatzki, MD, Wolfgang Holter, MD, Tobias Feuchtinger, MD, Hans-Peter Gruettner, MD, Stefan Zielen, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2005) 106 (11): 84.

https://doi.org/10.1182/blood.V106.11.84.84

Published: 2005

NARROW

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Similar Survival after Bone Marrow Versus Peripheral Blood Stem Cell Transplantation from Matched Unrelated Donors in Children with Hematologic Malignancies.

Vaccination with the Heptavalent Pneumococcal Conjugate Vaccine Prevenar™ Provides Early Protective Antibody Responses in Children after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Similar Survival after Bone Marrow Versus Peripheral Blood Stem Cell Transplantation from Matched Unrelated Donors in Children with Hematologic Malignancies.

Vaccination with the Heptavalent Pneumococcal Conjugate Vaccine Prevenar™ Provides Early Protective Antibody Responses in Children after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only